SCHEMBL7313971

SCHEMBL7313971

COc1ccc(I)c(CCC(C)=O)c1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56
KDM4E B2RXH2 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAPT P10636 1/20 0.56
MAOA P21397 1/20 0.56
SLC6A2 P23975 1/20 0.56
SLC6A3 Q01959 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
POLB P06746 1/20 0.49
HSD17B10 Q99714 1/20 0.44
MTNR1A P48039 4/20 0.43
MTNR1B P49286 2/20 0.43
ALDH1A1 P00352 1/20 0.43
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7314187 0.87 POLB (0.65) LMNAKDM4ECYP1A2MAPTPOLB
SCHEMBL7314138 0.86 POLB (0.48) LMNANPC1RAB9AKDM4ETP53
SCHEMBL7308036 0.83 HSD17B10 (0.50) LMNANPC1RAB9AKDM4ETP53
SCHEMBL11077966 0.82 MTNR1A (0.62) LMNANPC1RAB9AKDM4ETP53
SCHEMBL1886489 0.82 CYP4F2 (0.49) LMNANPC1RAB9ACYP1A2CYP3A4
SCHEMBL26046405 0.81 LMNA (0.56) LMNANPC1RAB9AKDM4ETP53
SCHEMBL13673154 0.80 MTNR1A (0.62) RAB9AKDM4ECYP1A2CYP3A4SMN1; SMN2
SCHEMBL7317718 0.80 CYP1A2 (0.48) CYP1A2CYP3A4POLBMTNR1A
SCHEMBL266527 0.79 NPC1 (0.58) LMNANPC1RAB9AKDM4ETP53
SCHEMBL7848234 0.79 LMNA (0.58) LMNANPC1RAB9AKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0250254-B1 CIS & TRANS STILBENES AND THEIR COMPOSITION FOR THE TREATMENT OF HYPERTENSION McNeilab, Inc. (US) 1991-06-19 EP disclosed
US-4960798-A Methods for the treatment of angina MCNEILAB, INC. (US) 1990-10-02 US disclosed
US-4898889-A Methods for the treatment of hypertension MCNEILAB, INC. (US) 1990-02-06 US disclosed
US-4742084-A Aralykyl (arylethynyl)aralkyl amines and their use as vasodilators and antihypertensives MCNEILAB, INC. (US) 1988-05-03 US disclosed
EP-0155079-B1 ACETYLENE AMINES AND THEIR USE AS VASODILATORS AND ANTIHYPERTENSIVES McNeilab, Inc. (US) 1988-02-17 EP disclosed
US-4725602-A Acetylene amines and their use as vasodilators and antihypertensives MCNEILAB, INC. (US) 1988-02-16 US disclosed
EP-0250254-A1 Cis & trans stilbenes and their composition for the treatment of hypertension McNeilab, Inc. (US) 1987-12-23 EP disclosed
US-4661635-A ANTIARRHYTHMIA AGENTS MCNEILAB, INC. (US) 1987-04-28 US disclosed
EP-0155079-A1 Acetylene amines and their use as vasodilators and antihypertensives McNeilab, Inc. (US) 1985-09-18 EP disclosed
EP-0146271-A2 Aralykyl (arylethynyl) aralkyl amines for use as vasodilators and antihypertensives McNeilab, Inc. (US) 1985-06-26 EP disclosed
EP-0145361-A2 Acetylene derivatives for the treatment of hypertension and angina McNeilab, Inc. (US) 1985-06-19 EP disclosed